Liuhto, N., Tuominen, J., Manni, N., Hakamäki, M., Lankinen, R., Toukola, T., Virtanen, J., Metsärinne, K., Järvisalo, M. J., Hellman, T. (2026). Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0353258